Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)
Nu open voor aanvraagWaar het om gaat
Deze actie richt zich op het ontwikkelen van productie van stabiele isotopen voor nucleaire geneeskunde, met focus op TRL 5-7 en marktgerichte activiteiten.
Samenvatting
Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)
Vergelijkbare regelingen
Dichtstbij qua inhoud — ook over de taalgrens (RVO ↔ EU-calls), via embeddings.
- Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI) · EU · 100% · open
- Strengthening a European user facility for nuclear research · EU · 89% · open
- Enhancing the European nuclear competence area · EU · 89% · open
- European Partnership for research in radiation protection and detection of ionising radiation · EU · 89% · open
- Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines · EU · 89% · open
- Critical Facilities Serving Space EEE components for EU non-dependence – High and Very High Energy Irradiation Test Facility Market Deployment · EU · 89% · open